ATE220420T1 - Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen - Google Patents

Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen

Info

Publication number
ATE220420T1
ATE220420T1 AT94925870T AT94925870T ATE220420T1 AT E220420 T1 ATE220420 T1 AT E220420T1 AT 94925870 T AT94925870 T AT 94925870T AT 94925870 T AT94925870 T AT 94925870T AT E220420 T1 ATE220420 T1 AT E220420T1
Authority
AT
Austria
Prior art keywords
synthesizing
biologically active
active compounds
identifying biologically
biocatalytic methods
Prior art date
Application number
AT94925870T
Other languages
English (en)
Inventor
J Wesley Fox
Jonathan S Dordick
Douglas S Clark
Original Assignee
Albany Molecular Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Molecular Res Inc filed Critical Albany Molecular Res Inc
Application granted granted Critical
Publication of ATE220420T1 publication Critical patent/ATE220420T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0099—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor comprising robots or similar manipulators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00686—Automatic
    • B01J2219/00691—Automatic using robots
AT94925870T 1993-08-13 1994-08-12 Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen ATE220420T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10627993A 1993-08-13 1993-08-13
PCT/US1994/009174 WO1995005475A1 (en) 1993-08-13 1994-08-12 Biocatalytic methods for synthesizing and identifying biologically active compounds

Publications (1)

Publication Number Publication Date
ATE220420T1 true ATE220420T1 (de) 2002-07-15

Family

ID=22310552

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94925870T ATE220420T1 (de) 1993-08-13 1994-08-12 Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen

Country Status (12)

Country Link
US (1) US20020039723A1 (de)
EP (1) EP0713533B1 (de)
JP (1) JPH09504424A (de)
KR (1) KR960704064A (de)
AT (1) ATE220420T1 (de)
AU (1) AU7564794A (de)
CA (1) CA2169456A1 (de)
DE (1) DE69430954T2 (de)
DK (1) DK0713533T3 (de)
ES (1) ES2179847T3 (de)
PT (1) PT713533E (de)
WO (1) WO1995005475A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2295152A (en) * 1994-11-18 1996-05-22 Pfizer Ltd Preparation of a library of compounds by solid-phase synthesis
US6261813B1 (en) 1995-09-11 2001-07-17 Albany Molecular Research, Inc. Two step enzymatic acylation
EP1641910B1 (de) 2003-07-02 2013-02-20 Verenium Corporation Glucanasen, diese codierende nukleinsäuren und verfahren zur herstellung und verwendung davon
US20080070291A1 (en) 2004-06-16 2008-03-20 David Lam Compositions and Methods for Enzymatic Decolorization of Chlorophyll
NZ599522A (en) 2005-05-09 2013-11-29 Theranos Inc Point-of-care fluidic systems and uses thereof
WO2009020459A2 (en) 2006-08-04 2009-02-12 Verenium Corporation Glucanases, nucleic acids encoding them and methods for making and using them
CN103323610B (zh) * 2007-10-02 2016-12-28 赛拉诺斯股份有限公司 模块化现场护理装置及其应用
UA111708C2 (uk) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. Спосіб рафінування олії
US8754054B2 (en) 2010-07-09 2014-06-17 Albany Molecular Research, Inc. Antibacterial compounds, methods of making them, and uses thereof
TWI639703B (zh) 2011-01-21 2018-11-01 賽瑞諾斯有限公司 樣本使用最大化之系統及方法
AU2012236641B2 (en) 2011-03-29 2017-05-04 Kellanova Heat recovery system
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
CN104673850A (zh) * 2015-03-20 2015-06-03 北京农学院 异硫氰酸烯丙酯的固定化酶转化制备方法
CN112725174B (zh) * 2020-12-28 2022-09-06 黑龙江省农业科学院生物技术研究所 一种用于生物印迹酶的制备装置及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

Also Published As

Publication number Publication date
ES2179847T3 (es) 2003-02-01
WO1995005475A1 (en) 1995-02-23
AU7564794A (en) 1995-03-14
EP0713533A1 (de) 1996-05-29
CA2169456A1 (en) 1995-02-23
DE69430954D1 (de) 2002-08-14
DE69430954T2 (de) 2003-03-13
EP0713533B1 (de) 2002-07-10
KR960704064A (ko) 1996-08-31
PT713533E (pt) 2002-11-29
US20020039723A1 (en) 2002-04-04
DK0713533T3 (da) 2002-11-04
JPH09504424A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
ATE220420T1 (de) Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
GB2006181A (en) Growth of biological material
AU2813089A (en) Use of a glycine b partial agonist for memory and learning enhancement or treatment of a cognitive disorder
DE69712900T2 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
DE69739532D1 (de) Prozess für die deacylierung von zyklischen lipopeptiden.
ATE199709T1 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta- lactonresten
DE69425940T2 (de) Enzymatische synthese von ceramiden und hybrid-ceramiden
ATA9391A (de) Reaktor zur durchfuehrung biologischer reaktionen mittels biokatalysatoren
DE59203370D1 (de) Reaktor und Verfahren zur Durchführung heterogenkatalytischer Gasphasenreaktionen.
ES2150980T3 (es) Un procedimiento para producir inmunosupresores y una nueva especie microbiana a emplear en el mismo.
BG102350A (en) New derivatives of 5-0-desozaminyl-6-0-methylerythronolide a, method for their preparation and usage for the preparation of biologically active products
ES2176224T3 (es) Proceso para la produccion de proteina.
GEP19991790B (en) C-2’ Hydroxyl-Bezyl Protected, N-Carbamate Protected (2R,3S)-3-Phenylisoserine and Production Process Therefor
ATE138378T1 (de) Enantioselektive synthese von antifolaten
DE69320906D1 (de) Mikroorganismen und Verfahren zur biologischen Entfernung von Nitratderivaten
DE69527088T2 (de) Tierkotbehandlungsmaterial und verfahren zu dessen herstellung
DK347788A (da) Teicoplaninlignende forbindelser, fremgangsmaade og mikroorganisme til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
BR9205255A (pt) Aril aquil esteres de acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antraceno carboxilico com atividade terapeutica
HUP0001048A2 (hu) Új vegyületek
DE69620786T2 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
FI102083B (fi) Menetelmä L-karnitiinin valmistamiseksi epäjatkuvasti mikrobiologista tietä
ES2145292T3 (es) Procedimiento bacteriano para la resolucion de cis-dioles racemicos.
DE69317343D1 (de) Verwendung eines direkten Inhibitors von Thrombin zur Herstellung eines Arzneimittels mit thrombolytischer Aktivität
DE69812910T2 (de) Herstellung von ungesättigten verbindungen und deren carbonsäure-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee